期刊文献+

产超广谱β-内酰胺酶细菌流行病学研究 被引量:2

Epidemiologic Study of Bacteria with Extended-spectrum β-lactamases
下载PDF
导出
摘要 超广谱β-内酰胺酶(ESBLs)是由质粒介导,能水解青霉素、广谱头孢菌素及单环类抗生素并产生耐药。各地区ESBLs的检出率、基因分型各不相同,细菌质粒上可以同时携带≥2种的ESBL编码基因。产ESBLs菌感染为多种危险因素所致,临床治疗产ESBLs菌感染应首选碳青霉烯类抗生素。 Extended-spectrum β-lactamases(ESBLs) is mediated by plasmids, which can hydrolyze penicilin, cephalosperin with wide spectrum and helices antibiotics and then result in durg resistance. Detection rate, Genotyping of ESBLs are different in different area. bacterial plasmid can carry two or more coding genes of ESBL. So bacteria infection with ESBLs often results from many risk factors, and carbopenems antibiotics is the first choice in its clinical therapy.
出处 《医学综述》 2007年第21期1661-1663,共3页 Medical Recapitulate
关键词 超广谱Β-内酰胺酶 流行病学 基因分型 危险因素 Extended-spectrum β-lactamases Epidemiology Genotyping Risk factor
  • 相关文献

参考文献20

二级参考文献48

  • 1Baraniak A, Fiett J, Sulikowska A, et al. Countrywide spread of CTX M 3 extended - spectrum β - lactamase producing microorganisms of the family Enterobacteriaceae in Poland[J]. Antimicrob Agents Chemother, 2002; 46:151 -160.
  • 2Emery CL, Weymouth LA. Detection and clinical significance of extended - spectrum beta lactamases in a tertiary care medical center[J].J clin Microbiol,1997;35:2061-2067.
  • 3NCCLS. Performance Standards for Antimicrobial Susceptibility Testing; Ninth Informational Supplement[J]. 1999,M100-S9,19(1) :45 -50.
  • 4SambrookJ FritschEF ManiatisT.分子克隆实验指南(第2版)[M].北京:科学出版社,1999.681-683.
  • 5Medeires AA. Evolution and dissemination of β- lacta mase accelerated by generations of β- lactama antibiotics[J].Clin Infect Dis, 1997; 24 (Suppl): s19.
  • 6Du Bios SK, Marriatt MS, Amyes SGB. TEM - and SHV - derived extended - spectrum β - lactamases: relationship between selection, structure and function [J]- J Antimicrob Chemother, 1995; 35: 7-22.
  • 7Bush g,Jacoby GA, Medeires AA. A functional classification scheme for β- lactamases and its correlation with molecular structure[J]. Antimicrob Agents Chemother, 1995; 39:1211 -1233.
  • 8Moosdeen F. The evolution of resistance to cephalosporins[J]. Clin Infect Dis, 1997,24(3) : 487-493.
  • 9Jacoby GA. Epidemiology of extended-spectrum β-lactamases[J]. Clin Infect Dis,1998,27(1) :81 -83.
  • 10National Committee for Clinical Laboratory Standards. Performance standard for antimicrobial susceptibility testing[S].Ninth informational supplement (M100-S9). Wayne, Pennsylvania : NCCLS, 2002.

共引文献252

同被引文献15

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部